These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19450091)

  • 41. Systematic review and meta-analysis of budesonide/formoterol in a single inhaler.
    Edwards SJ; Gruffydd-Jones K; Ryan DP
    Curr Med Res Opin; 2007 Aug; 23(8):1809-20. PubMed ID: 17597557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Budesonide/formoterol maintenance and reliever therapy: an effective and easy approach to asthma management].
    Mungan D
    Tuberk Toraks; 2009; 57(1):93-108. PubMed ID: 19533446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
    van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
    Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing.
    Ställberg B; Olsson P; Jörgensen LA; Lindarck N; Ekström T
    Int J Clin Pract; 2003 Oct; 57(8):656-61. PubMed ID: 14627173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD.
    Tronde A; Gillen M; Borgström L; Lötvall J; Ankerst J
    J Clin Pharmacol; 2008 Nov; 48(11):1300-8. PubMed ID: 18974284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
    Hampel FC; Martin P; Mezzanotte WS
    J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.
    van Schayck OC; Haughney J; Aubier M; Selroos O; Ekström T; Ostinelli J; Buhl R
    Respir Med; 2012 Feb; 106(2):189-96. PubMed ID: 22119455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers.
    Adi H; Young PM; Traini D
    J Pharm Pharmacol; 2012 Sep; 64(9):1245-53. PubMed ID: 22881437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma.
    Pilcher J; Patel M; Smith A; Davies C; Pritchard A; Travers J; Black P; Weatherall M; Beasley R; Harwood M;
    Respirology; 2014 Aug; 19(6):842-51. PubMed ID: 24889937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
    Murphy K; Nelson H; Parasuraman B; Boggs R; Miller C; O'Dowd L
    Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined budesonide/formoterol turbuhaler treatment of asthma.
    Remington TL; Heaberlin AM; DiGiovine B
    Ann Pharmacother; 2002 Dec; 36(12):1918-28. PubMed ID: 12452756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life.
    Price DB; Williams AE; Yoxall S
    Respir Res; 2007 Jul; 8(1):46. PubMed ID: 17610727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone.
    Löfdahl CG; Ericsson A; Svensson K; Andreasson E
    Pharmacoeconomics; 2005; 23(4):365-75. PubMed ID: 15853436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.
    Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S
    J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.
    Berger WE; Gillen M; Eckerwall G; Uryniak T; Trudo FJ; Lampl KL
    Allergy Asthma Proc; 2014; 35(2):134-40. PubMed ID: 24717790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Budesonide/formoterol maintenance and reliever therapy versus conventional best practice.
    Demoly P; Louis R; Søes-Petersen U; Naya I; Carlsheimer A; Worth H; Almeida J; Sears MR
    Respir Med; 2009 Nov; 103(11):1623-32. PubMed ID: 19762222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPD.
    Tashkin DP
    Expert Rev Respir Med; 2010 Dec; 4(6):703-14. PubMed ID: 21128746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Budesonide/formoterol therapy: effective and appropriate use in asthma and chronic obstructive pulmonary disease.
    Mapel DW; Roberts MH; Davis J
    J Comp Eff Res; 2020 Mar; 9(4):231-251. PubMed ID: 31983228
    [No Abstract]   [Full Text] [Related]  

  • 60. A smarter way to manage asthma with a combination of a long-acting beta(2)-agonist and inhaled corticosteroid.
    Selroos O
    Ther Clin Risk Manag; 2007 Jun; 3(2):349-59. PubMed ID: 18360644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.